Rethinking the Importance of Intraocular Drug Penetration
Recent work has challenged conventional thinking about the meaning and
determinants of antibiotic potency in the ocular situation. In addition, the
presence of new topical antibiotic formulations with properties different
from other drugs in the class, changes the options available to physicians.
By being made aware of these findings, ophthalmologists will be better able
to evaluate new medications and select optimal antibiotic agents, especially
for surgical prophylaxis.
This issue of Rethinking Ocular Antiinfectives is presented as both a print
report and a video--participants can choose the format they prefer. Using
pharmacokinetic principles, this issue will challenge some assumptions about
the importance of intraocular drug penetration for the prevention of
postoperative ophthalmic infections. Ophthalmologists will be able to apply
this information immediately as they seek out the best options for
preventing and managing ocular infection.
Rethinking Ocular Antiinfectives is an independent Continuing Medical Education Program jointly sponsored by the University of Florida College of Medicine and Candeo Clinical/Science Communications, LLC and is supported by an unrestricted educational grant from Bausch + Lomb, Inc. ©2010 Candeo Clinical/Science Communications, LLC.
Faculty: John Sheppard, MD, MMSc & Susanne Gardner, PharmD
View the new CME, Rethinking the Importance of Intraocular Drug Penetration, Issue 3:
Print
Webinar